Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Immunotherapy. 2012 May;4(5):511–527. doi: 10.2217/imt.12.38

Figure 1. Enhancing ADCC.

Figure 1

FcR: Fc receptor; HDACi: Histone deacetylase inhibitor; IMiD: Immunomodulator; KIR: Killer immunoglobulin-like receptor;

MΦ: Macrophage; mAb: Monoclonal antibody; pDC: Plasmacytoid dendritic cell; TLR: Toll-like receptor.